AKT2 and rheumatoid arthritis: In some reports, hsa-miR-650 targets AKT serine/threonine kinase 2 (AKT2) and inhibits the proliferation, migration and invasion of synovial fibroblasts in individuals with rheumatoid arthritis (Xu et al., 2017).